As 2023 comes to a close, what were the largest mergers and acquisitions and expansions made by CDMOs/CMOs in 2023? DCAT Value Chain Insights looks at which companies topped the headlines this year and the leading moves they made.

Key topics: (see Chapter Markers in drop down menu in audio player above) 

• Baxter (2:11)
• Samsung Biologics (3:39)
• Lotte Biologics (5:01)
• Fujifilm Diosynth Biotechnologies (7:04)
• Lonza (10:42)
• Cambrex (13:10)
• Expansions in peptides, oligonucleotides (15:27)
• Bachem (15:49)
• Agilent Technologies (17:01)
• WuXi STA (17:51)
• CordenPharma (19:01)
• Ajinomoto (20:32)
• Bain’s acquisition of F.I.S. (21:19)
• eureKING (22:32)
• New CDMOs enter the market (23:41)
• Bridgewest Group (23:49)
• SynCrest (24:27)
• NewBiologix (25:20)
• Ascend Gene & Cell Therapies (26:19)

Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show